Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 15, 2019

Gilead, Galapagos sign 10-year research and development deal

Biopharmaceutical firm Gilead Sciences has entered into a 10-year global research and development collaboration with Galapagos.

Continue
Image: Gilead and Galapagos have signed 10-year research and development deal. Photo: courtesy of Emilian Danaila from Pixabay.
July 11, 2019

FDA accepts to review Sanofi’s multiple myeloma candidate isatuximab

Image: FDA has set a target action date of 30 April 2020 to take a decision on isatuximab. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.
July 11, 2019

Nexus Pharmaceuticals to build sterile injectable production facility in Wisconsin

Image: Nexus Pharmaceuticals will build sterile injectable manufacturing facility in Wisconsin’s village Pleasant Prairie. Photo: courtesy of Integrated Project Services (IPS).

Contracts

May 22, 2019

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Image: WuXi Vaccines will build an integrated vaccine manufacturing facility. Photo: courtesy of Arek Socha / Pixabay.

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Deals

Deals July 10, 2019

Altimmune to buy Presidio Partners portfolio firm Spitfire Pharma

Pharmaceutical Business Review

MorphoSys secures option to license Vivoryon’s QPCTL inhibitors for cancer

Boehringer Ingelheim, Yuhan sign £689m NASH license deal

Novartis wraps up acquisition of Takeda’s dry eye drug Xiidra

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Webinar: Introduction to the GMP Standard for OTC Drug Manufacture NSF/ ANSI 455-4 – 2018
Webinar: Introduction to the GMP Standard for OTC Drug Manufacture NSF/ ANSI 455-4 – 2018
Integrated Industrial Vibratory Sieving Solution for High-Containment Pharmaceutical Production Lines
Integrated Industrial Vibratory Sieving Solution for High-Containment Pharmaceutical Production Lines
Industry Leaders Come on Board as NMiTE Adds Engineering Expertise
Industry Leaders Come on Board as NMiTE Adds Engineering Expertise
SCHOTT RealView™ Glass Wafers Expand Field of View in Augmented and Mixed Reality
SCHOTT RealView™ Glass Wafers Expand Field of View in Augmented and Mixed Reality
Exclusive Supplier of DYNO-MILL and DYNA-MIX Technology for North US Announced
Exclusive Supplier of DYNO-MILL and DYNA-MIX Technology for North US Announced

Suppliers

Whitepapers

The Biggest Threats to Pharmaceutical Companies
The Biggest Threats to Pharmaceutical Companies
World’s First CBD of Natural Origin and GMP Pharma Grade Hits the Market
World’s First CBD of Natural Origin and GMP Pharma Grade Hits the Market
Upmarket Cannabinoid Solutions by CBDepot
Upmarket Cannabinoid Solutions by CBDepot